PTSD is the Most Common Condition Treated by Medical Cannabis in Illinois

In Illinois, the number of patients who use medical cannabis for post traumatic stress disorder (PTSD) surpasses that of any other condition, according to a new state report.

The report states that PTSD has become the most common medical ailment among patients who are participating in the state’s legal medical cannabis program. The report also found that the program has grown 83% this year to over 46,000 patients.

The number of patients with PTSD who are legal medical cannabis patients doubled in fiscal year 2018, to more than 4,000. This surpassed fibromyalgia (3,400 patients), and cancer (2,500 patients), which were #1 and #2 last year. Rounding out the top five are spinal cord disease and injuries and traumatic brain injuries.

Read morePTSD is the Most Common Condition Treated by Medical Cannabis in Illinois

Georgia House Votes to Add PTSD and Intractable Pain to State’s Medical Marijuana Program

Georgia’s House of Representatives has overwhelmingly passed legislation to expand the state’s medical marijuana program.

The House approved House Bill 764 Wednesday in a 145 to 17 vote, sending it to the Senate for consideration. The measure would allow those with post traumatic stress disorder (PTSD) and  intractable pain to join the state’s Low THC Oil Patient Registry. The registry, established in 2015, allows those with certain medical conditions to legally possess and use up to 20 ounces of low-THC cannabis oil .

If the bill is approved by the Senate, it will be sent to Governor Nathan Deal for consideration; Deal has expressed support for the measure, indicating he would likely sign it into law if given the chance. If the measure does become law, PTSD and intractable pain would join epilepsy, cancer, Parkinson’s disease, ALS, sickle cell anemia, multiple sclerosis, Crohn’s disease and mitochondrial disease as qualifying conditions.

Read moreGeorgia House Votes to Add PTSD and Intractable Pain to State’s Medical Marijuana Program

Study: Cannabinoids May Prevent Depressive and PTSD-Like Symptoms Following Severe Stress

Cannabinoids may prevent both depressive and PTSD-like symptoms following exposure to severe stress, according to a new study being published by the journal Progress in Neuro-Psychopharmacology & Biological Psychiatry.

“Posttraumatic stress disorder (PTSD) is a debilitating condition highly comorbid with depression”, begins the abstract of the study, which was also published by the U.S. National Institute of Health. “The endocannabinoid (eCB) system and brain-derived neurotrophic factor (BDNF) are suggestively involved in both disorders.” For the study, researchers “examined whether cannabinoids can prevent the long-term depressive-like symptoms induced by exposure to the shock and situational reminders (SRs) model of PTSD.”

Researchers administered a compound meant to mimic the effects of natural cannabinoids in rats two hours after a severe shock. “Cannabinoids prevented the shock/SRs-induced alterations in social recognition memory, locomotion, passive coping, anxiety-like behavior, anhedonia, fear retrieval, fear extinction and startle response as well as the decrease in BDNF levels in the hippocampus and prefrontal cortex (PFC)”, states the study. “Furthermore, significant correlations were found between depressive-like behaviors and BDNF levels in the brain.”

Read moreStudy: Cannabinoids May Prevent Depressive and PTSD-Like Symptoms Following Severe Stress

New York Governor Signs Bill Allowing Medical Cannabis for PTSD

New York Governor Andrew Cuomo has signed into law a bill that allows the medical use of cannabis for those with post traumatic stress disorder (PTSD).

The bipartisan legislation (A7006) adds PTSD to New York’s medical cannabis program, allowing those with the condition to become legal medical cannabis patients. As with other conditions that are part of the state’s medical cannabis program, those with PTSD will need to receive a recommendation from a physician and register with the state before they can legally purchase and use medical cannabis. Governor Cuomo signed the bill today, on Veterans Day.

A7006 received widespread, bipartisan support in New York’s Legislature. It was approved by the Assembly in May with a vote of 131 to 8, and was subsequential passed by the Senate 50 to 13. New York now becomes the 28th state to allow medical cannabis for PTSD.

Read moreNew York Governor Signs Bill Allowing Medical Cannabis for PTSD

Delaware Governor Signs Medical Marijuana PTSD Bill

Delaware Governor John Carney has signed into law a bill that allows those with post traumatic stress disorder (PTSD) to more easily become medical marijuana patients.

Governor Carney has signed the Bravery Bill into law, allowing those with PTSD to become legal medical marijuana patients if they receive a recommendation from a licensed physician. Before the new law those with PTSD could only get approval for medical marijuana use if they were recommended it by a licensed psychiatrist.

The Bravery Bill was introduced by Senate Majority Leader Margaret Rose Henry, and received strong bipartisan support in both the House of Representatives and Senate.

Read moreDelaware Governor Signs Medical Marijuana PTSD Bill

FDA Grants Breakthrough Therapy Designation to MDMA (Ecstasy) for PTSD

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA (the main compound found in ecstasy) for the treatment of posttraumatic stress disorder (PTSD).

The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of posttraumatic stress disorder (PTSD). MAPS and the FDA have also reached agreement under the Special Protocol Assessment Process (SPA) for the design of two upcoming Phase 3 trials (MAPP1 and MAPP2) of MDMA-assisted psychotherapy for patients with severe PTSD.

MDMA-assisted psychotherapy is a novel treatment package that combines psychotherapeutic techniques with three administrations of MDMA as a pharmacological adjunct.

Read moreFDA Grants Breakthrough Therapy Designation to MDMA (Ecstasy) for PTSD

New Hampshire Governor Signs Bill Allowing Medical Marijuana for PTSD and “Moderate to Severe Pain”

Legislation expanding New Hampshire’s medical marijuana program has been signed into law by Governor Chris Sununu.

(Photo: mymatrixx.com)

House Bill 160, signed into law Wednesday by Governor Sununu, expands the state’s list of qualifying medical cannabis conditions by adding post traumatic stress disorder (PTSD), Ehlers-Danlos syndrome, and moderate to severe pain. The legislation also allows medical providers to certify patients for any medical condition that produces a qualifying symptom.

The new law, which takes effect August 27th, requires the Department of Health and Human Services to inform patients about the possibility that certain rights may be denied by federal agencies due to their medical marijuana use.

Read moreNew Hampshire Governor Signs Bill Allowing Medical Marijuana for PTSD and “Moderate to Severe Pain”

New York Legislature Approves Measure to Allow Medical Marijuana for PTSD

A bipartisan proposal to add post-traumatic stress disorder (PTSD) as a qualifying medical marijuana condition in New York has been passed by the state’s legislature and sent to Governor Andrew Cuomo for consideration.

The Senate passed Senate Bill 5629 today with a 50 to 13 vote. The Assembly version of the measure, Assembly Bill 7006, was passed in May with an overwhelming 131 to 8 vote. The legislation allows those with PTSD to legally purchase, possess and use medical cannabis, given they receive a recommendation from a physician and register with the state.

“State lawmakers are standing up for thousands of New Yorkers who are suffering from PTSD and might benefit from medical marijuana,” said Kate Bell, legislative counsel for the Marijuana Policy Project. “We hope Gov. Cuomo will do the same and sign this important legislation. With a single swipe of his pen, he can help countless people find relief.”

Read moreNew York Legislature Approves Measure to Allow Medical Marijuana for PTSD

Colorado Governor Signs Bill Allowing Medical Marijuana for PTSD and Acute Stress Disorder

Legislation expanding Colorado’s medical marijuana program has been signed into law by Governor John Hickenlooper.

Senate Bill 17signed into law yesterday by Governor Hickenlooper – would create “a statutory right to use medical marijuana for a patient with acute stress disorder or post-traumatic stress disorder.” The bill “creates the same rights, limitations, and criminal defenses and exceptions as the constitutional right to use medical marijuana” for all other conditions that currently qualify someone to become a legal medical cannabis patient.

The measure passed the Senate in March with a 34 to 1 vote, and was approved in April by the House of Representatives.

Read moreColorado Governor Signs Bill Allowing Medical Marijuana for PTSD and Acute Stress Disorder

Legislation Allowing Medical Cannabis for PTSD and Chronic Pain Approved by New Hampshire Legislature

A measure allowing medical cannabis for post traumatic stress disorder and chronic pain has been approved by New Hampshire’s Senate.

The legislation has already been approved by the state’s House of Representatives; it will soon be sent to Governor Chris Sununu for consideration.

The proposed law would allow those with post traumatic stress disorder (PTSD) and chronic pain to become legal medical cannabis patients by adding the conditions to the state’s medical cannabis program. Those with PTSD or chronic pain would first need to receive a recommendation from a physician, and register with the state, before they can legally purchase, possess and use cannabis for medical purposes; this is the case with all other qualifying medical conditions.

Read moreLegislation Allowing Medical Cannabis for PTSD and Chronic Pain Approved by New Hampshire Legislature